… by being trapped in the polymer coating, the use of solvents and surfactants can … the release
profile of the combinations of two drugs of paclitaxel/sirolimus in vitro (measuring the drug …

… settings, drug-eluting polymers for coating of ureteral stents have … A mixture containing 0.6
ml coating solution and 0.5 ml … the efficacy of the drug release from the coated stents by high-…

… release profile of the combinations of two drugs of paclitaxel/sirolimus in vitro (measuring
the drug … model for drug release in PLGA biodegradable stent coatings coupled with polymer …

… , and the drug released from the internal surface of the stent will mix into the … drug release
behaviors in vivo and in vitro. During the in vitro drug release experiment, drug coated stents …

… drug-eluting stent carries sirolimus or its derivatives [8]. … paclitaxel and sirolimus nano-drug
delivery system. The effects of … is the main drug currently used in drug coating balloons. In the …

… The second and outer stent layer presents a paclitaxel drug mix … In some studies, in-vitro
examination with cpTi showed … coating is utilized for holding and for controlled drug release …

… alternative to drug-eluting stents, whereby drug is delivered … with drug release from durable
polymer coated stents wherein … in vitro and in vivo dissolution rates of the same coating to be …

… In vitro drug release kinetics of the fabricated stent reveals a … conventional drug-eluting
stents, combinations of drugs have … over a metallic stent and evaluate its in vivo biocompatibility. …

… Drug-Eluting Stents (DESs) for the treatment of obstructive … DES) (ie stents coated with two
different drugs) was conceived … the literature investigating different combinations of drugs [10]. …

… of drug-eluting stents (DESs) to deliver antiproliferative drugs … in layer-by-layer coating
and drug delivery. The advances in … and standardized in vitro and in vivo tests before clinical …